SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,118,000 | +47.3% | 25,000 | -44.3% | 1.93% | +48.4% |
| Q3 2017 | $2,796,000 | -48.3% | 44,872 | -33.9% | 1.30% | -65.8% |
| Q2 2017 | $5,405,000 | -23.3% | 67,872 | -31.5% | 3.80% | +5.2% |
| Q1 2017 | $7,045,000 | +20.9% | 99,123 | -13.1% | 3.61% | -13.5% |
| Q4 2016 | $5,827,000 | -4.6% | 114,123 | -14.0% | 4.17% | -5.1% |
| Q3 2016 | $6,110,000 | +29.2% | 132,674 | -15.5% | 4.40% | +8.1% |
| Q2 2016 | $4,729,000 | +3.5% | 156,958 | +10.1% | 4.07% | -1.7% |
| Q1 2016 | $4,571,000 | +353.5% | 142,570 | +498.3% | 4.14% | +373.3% |
| Q3 2015 | $1,008,000 | -54.2% | 23,829 | -45.6% | 0.87% | -41.5% |
| Q1 2015 | $2,199,000 | +69.8% | 43,770 | +23.7% | 1.49% | +137.0% |
| Q4 2014 | $1,295,000 | – | 35,370 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |